Continuous flow left ventricular assist device technology has influenced wait times and affected donor allocation in cardiac transplantation

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 6, 2014, Pages

  Taghavi, Sharven ^a   Jayarajan, Senthil N ^a   Komaroff, Eugene ^b   Mangi, Abeel A ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONGENITAL HEART DISEASE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CORONARY ARTERY DISEASE; DEVICE INFECTION; DIABETES MELLITUS; EXTRACORPOREAL OXYGENATION; FEMALE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LENGTH OF STAY; MALE; ORGAN DONOR; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SURVIVAL; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

ADULT; AGED; DONOR SELECTION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT; WAITING LISTS; YOUNG ADULT;

EID: 84901191871     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2014.02.001     Document Type: Article

References (17)

1. R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy Ann Thorac Surg 86 2008 1227 1234
2. J.G. Rogers, K.D. Aaronson, A.J. Boyle, S.D. Russell, C.A. Milano, and F.D. Pagani et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients J Am Coll Cardiol 55 2010 1826 1834
3. J.K. Kirklin, D.C. Naftel, R.L. Kormos, L.W. Stevenson, F.D. Pagani, and M.A. Miller et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting J Heart Lung Transplant 31 2012 117 126
4. OPTN Allocation of Thoracic Organs, 2013. Available at: http://optn.transplant.hrsa.gov/PoliciesandBylaws2/policies/pdfs/policy-9.pdf. Accessed October 17, 2013.
5. K. Lietz, J.W. Long, A.G. Kfoury, M.S. Slaughter, M.A. Silver, and C.A. Milano et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-rematch era implications for patient selection Circulation 116 2007 497 505
6. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, D.F. Heitjan, L.W. Stevenson, and W. Dembitsky et al. Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
7. N. Uriel, U.P. Jorde, S. Woo Pak, J. Jiang, K. Clerkin, and H. Takayama et al. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation J Heart Lung Transplant 32 2013 188 195
8. L.W. Miller, F.D. Pagani, S.D. Russell, R. John, A.J. Boyle, and K.D. Aaronson et al. Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
9. A.J. Boyle, S.D. Russell, J.J. Teuteberg, M.S. Slaughter, N. Moazami, and F.D. Pagani et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation J Heart Lung Transplant 28 2009 881 887
10. J.K. Kirklin, D.C. Naftel, R.L. Kormos, L.W. Stevenson, F.D. Pagani, and M.A. Miller et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients J Heart Lung Transplant 32 2013 141 156
11. T. Dardas, N.A. Mokadam, F. Pagani, K. Aaronson, and W.C. Levy Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time J Am Coll Cardiol 60 2012 36 43
12. R. John, K. Lietz, M. Schuster, Y. Naka, V. Rao, and D.M. Mancini et al. Immunologic sensitization in recipients of left ventricular assist devices J Thorac Cardiovasc Surg 125 2003 578 591
13. D.L. Joyce, R.E. Southard, G. Torre-Amione, G.P. Noon, G.A. Land, and M. Loebe Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes J Heart Lung Transplant 24 2005 2054 2059
14. R. John, F.D. Pagani, Y. Naka, A. Boyle, J.V. Conte, and S.D. Russell et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables J Thorac Cardiovasc Surg 140 2010 174 181
15. R. John, P. Eckman, M. Colvin-Adams, S.J. Shumway, and K. Liao Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices J Thorac Cardiovasc Surg 145 2013 575 581
16. N.G. Smedira, K.J. Hoercher, D.Y. Yoon, J. Rajeswaran, L. Klingman, and R.C. Starling et al. Bridge to transplant experience: factors influencing survival to and after cardiac transplant J Thorac Cardiovasc Surg 139 2010 1295 1305
17. S.P. Pinney Timing isn't everything: donor heart allocation in the present LVAD era J Am Coll Cardiol 60 2012 52 53